← Patent-cliff monitor Loss of exclusivity June 2036 latest FDA-listed patent expiry
Drug detail Brand name DESCOVY Active ingredient EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE Strength 200MG;EQ 25MG BASE Dosage form TABLET Route ORAL Modality Small molecule FDA approval April 2016 Marketing status RX
Listed patents Patent Expires Type 12678408 June 2036 product 12661323 June 2036 product 12648911 June 2036 use U-1259 12629338 June 2036 product 8754065*PED February 2033 — 9296769*PED February 2033 — 9296769 August 2032 substance, product 8754065 August 2032 substance, product
Regulatory exclusivity Code Expires ODE-556 June 2032 M-316 June 2028
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.